Company Shares of Masimo Corporation (NASDAQ:MASI) Drops by -0.27%

Masimo Corporation (NASDAQ:MASI) has risen sharply, recording gains of 0.44% in the past 4 weeks. However, the stock has corrected -0.27% in the past 1 week, providing a good buying opportunity on dips. Masimo Corporation (NASDAQ:MASI) : During the past 4 weeks, traders have been relatively bearish on Masimo Corporation (NASDAQ:MASI), hence the stock is down -1.15% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.53% relative to the S&P 500.

The company shares have rallied 34.21% from its 1 Year high price. On Jun 9, 2016, the shares registered one year high at $53.55 and the one year low was seen on Feb 24, 2016. The 50-Day Moving Average price is $50.95 and the 200 Day Moving Average price is recorded at $42.78.

The stock has recorded a 20-day Moving Average of 1.37% and the 50-Day Moving Average is 6.57%.


Masimo Corporation (NASDAQ:MASI): stock turned positive on Friday. Though the stock opened at $52.12, the bulls momentum made the stock top out at $52.67 level for the day. The stock recorded a low of $52.07 and closed the trading day at $52.33, in the green by 0.65%. The total traded volume for the day was 711,738. The stock had closed at $51.99 in the previous days trading.

In an insider trading activity, The Officer (Chief Accounting Officer), of MASIMO CORP, Van Ramshorst David J had unloaded 5,000 shares at $52.5 per share in a transaction on June 30, 2016. The total value of transaction was $262,500. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

Masimo Corporation is a global medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Companys core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and optical gas monitoring. In addition, the Company offers Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system, which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.